The ASX is having a spirited end to the trading week so far this Friday. Earnings season has rolled on and is ending the week with a bang. One of the more interesting reports this session is from a popular ASX dividend share. Unlike most dividend payers this earnings season, this stock has just delivered a crushing 50% cut to its dividend. That popular ASX dividend share in question is none other than WAM Capital Ltd (ASX: WAM).

WAM Capital is a listed investment company (LIC) that has been on the ASX since 1999. Over this time, it has built up a reputation as a generous dividend payer. However, the company has struggled in recent years, with investors enduring a savage share price decline.

To illustrate, WAM Capital shares last topped out at about $2.50 a share back in 2017. Today, the company has opened sharply lower. WAM Capital shut up shop at $1.51 a share yesterday. But this morning, those same shares opened at $1.40 each before descending to $1.28 at the time of writing. That’s a one-day loss of 15.2%.

That puts this company’s losses over the past 12 months at 25.7%. Shareholders who have held on for the past five years are down a horrid 43.9%.

In other words, WAM Capital’s generous dividends have been the only thing saving investors’ returns. But now that looks set to change too.

WAM Capital shares plunge as dividend slashed 50%

As part of its latest earnings, released this morning, WAM Capital revealed that it can no longer afford to maintain the 7.75-cents-per-share dividend every six months. That’s the payout investors have been receiving on a biannual basis since FY 2020. Investors will receive a final dividend of 7.75 cents per share, partially franked to 60%, in October. But that will be the last of its kind, for at least a while.

In these earnings, WAM Capital has “announced an FY2027 full-year dividend target of 8.0 cents per share, comprising an interim dividend of 4.0 cents per share and a final dividend of 4.0 cents per share”.

This means that 2027’s payouts will be worth approximately half of the dividends that investors have become used to over the past six years or so. It is a calamitous and embarrassing moment for the company, whose investors will now enjoy the same record-low level of dividend income that they last received in 2009. As we’ve warned investors about, the dividends needed to be slashed because of the lack of profits to fund them. Here’s how WAM Capital justified it:

Since FY2020, the Board has maintained WAM Capital’s full year dividend at 15.5 cents per share. Over that period, the dividends paid by the Board exceeded the profits generated, drawing down the Company’s accumulated profits reserve. Maintaining the dividend at 15.5 cents per share is no longer sustainable with the profits reserve available.

WAM Capital has also told investors that they should not bank on getting 8 cents per share in dividends next year either, stating “the FY2027 dividend target is not a forecast or commitment of future dividends”. No wonder WAM Capital shares are copping a beating this Friday.

The post Ouch: WAM Capital shares crash 15% as dividend cut in half appeared first on The Motley Fool Australia.

More reading

• WAM Capital trims FY27 dividend after portfolio setback in FY26
• This popular ASX dividend stock has a 10% yield. That’s a problem
• This fund manager thinks these ASX shares are buys and have big potential!

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Boss Energy Ltd (ASX: BOE) recently released solid profit results and a new mining plan for its Honeymoon uranium operations in South Australia, but brokers are divided on the company’s future prospects.

Two of the brokers who released research reports on the company this week have buy recommendations on the stock, while one has a neutral rating.

I’ll get to the specifics of the share price targets they are forecasting shortly.

First, let’s have a look at what the company released.

A welcome return to profits

Boss recorded a net profit of $2.5 million for FY26, which was a $36.7 million improvement from the previous year.

Revenue doubled to $151.1 million, with the company paying an average realised price of US$74.4 per pound of uranium.

The company provided guidance for production of 1.25 to 1.3 million pounds of uranium in the current year, which the brokers said was below expectations.

The company said:

The production and cost profile reflects the mine-development uncertainty experienced since July 2025 and Boss’ disciplined decision to limit further investment in legacy wellfields, where the expected returns did not justify additional capital. This approach has preserved balance sheet strength while enabling continued investment in plant infrastructure and new value-accretive wellfields, to support the expected production ramp-up.

Boss also released a new feasibility study that envisages a wider-spaced well design for its in-situ leach mine and is forecast to keep the mine operating until at least FY34.

The company said its costs would decrease as a result, reflecting an increase in uranium concentration in the leach solution.

Brokers divided on the outlook for Boss Energy shares

The Canaccord Genuity team said they had factored in two further deposits, Jason’s and Gould’s Dam, into their valuation of the company, which they see providing options for mining from 2035.

They have reduced their price target on the company from $2.50 to $2, but that’s still well above the current price of $1.50.

Macquarie said the new mine design provided a credible pathway to production and the “wide spaced wellfield design appears likely to be quite effective in reducing costs given 50% less infrastructure and 28% higher … grades”.

The broker said the market may have focused too much on FY27 guidance in selling off the stock, and “Honeymoon value will be better demonstrated when fully ramped at 1.9Mlb/yr”.

Macquarie has a $1.80 price target on the company.

Meanwhile, UBS has a neutral rating on the stock and a price target of $1.50.

UBS said it was not factoring the other deposits into its valuation at this stage.

Boss Energy is valued at $753.5 million.

The post Are Boss Energy shares a buy, hold or sell on new mining plans? appeared first on The Motley Fool Australia.

More reading

• Boss Energy reports profit turnaround and more uranium production in FY2026
• These are the 10 most shorted ASX shares
• These are the 10 most shorted ASX shares
• Buy, hold, sell: Boss Energy, Northern Star, and Woodside shares
• Down 27%, are Boss Energy shares a buy, hold or sell?

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 4DMedical Ltd (ASX: 4DX) share price is in focus after the company posted a 21% lift in revenue to $7.1 million for FY26, with adjusted net loss improving 7% to $32.9 million.

What did 4DMedical report?

• Revenue from ordinary activities up 21% to $7.1 million
• Adjusted net loss down 7% to $32.9 million
• Statutory net loss expanded to $203 million (from $30.1 million a year ago), driven by significant non-cash items
• Gross margins remained above 90%
• No dividend declared or paid
• Net tangible assets per share improved to $0.17 (from negative $0.02)

What else do investors need to know?

4DMedical’s underlying SaaS revenue climbed 23%, supported by strong growth from B2B hospital and radiology partners, third-party AI distributors, and global medical technology companies. The loss at the statutory level included a major non-cash impact—remeasurement of the Pro Medicus loan and associated derivative financial instrument—reflecting complex accounting treatment rather than core business cash outflows.

The company raised $233 million through share placements and finished the year with a robust $278 million in cash, positioning it well for ongoing investment and expansion. No dividends were declared for FY26.

What did 4DMedical management say?

Dr. Andreas Fouras, Managing Director and CEO, commented:

4DMedical has maintained strong momentum throughout FY26, improving our adjusted net loss result and strengthening our balance sheet so we can accelerate future growth initiatives.

What’s next for 4DMedical?

Looking ahead, 4DMedical recently completed the acquisition of contextflow GmbH, an Austrian lung cancer screening technology company. The group also led a strategic investment in RevealDx, securing exclusive distribution rights for RevealAI-lung across key markets, including Europe, Australia, and New Zealand.

Management plans to continue scaling its commercial partnerships and integrating new technologies, while building a globally competitive medical imaging and AI platform.

4DMedical share price snapshot

Over the past 12 months, 4DMedical shares have risen nearly 700%, far outpacing the All Ordinaries Index (ASX: XAO).

View Original Announcement

The post 4DMedical share price rises as FY26 revenue climbs, losses moderate appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• These are the 10 most shorted ASX shares
• These are the 10 most shorted ASX shares
• 4DMedical shares are up 670% — but why have they halved?
• Are Pro Medicus shares now too cheap to ignore?

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.